These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31117293)
21. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Chang JT; Yang HT; Wang TC; Cheng AJ Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690 [TBL] [Abstract][Full Text] [Related]
22. Interferon-induced sensitization to apoptosis is associated with repressed transcriptional activity of the hTERT promoter in multiple myeloma. Lindkvist A; Ivarsson K; Jernberg-Wiklund H; Paulsson-Karlsson Y Biochem Biophys Res Commun; 2006 Mar; 341(4):1141-8. PubMed ID: 16460686 [TBL] [Abstract][Full Text] [Related]
23. Camptothecin induces c-Myc- and Sp1-mediated hTERT expression in LNCaP cells: Involvement of reactive oxygen species and PI3K/Akt. Dilshara MG; Jayasooriya RGPT; Choi YH; Kim GY Food Chem Toxicol; 2019 May; 127():53-60. PubMed ID: 30851366 [TBL] [Abstract][Full Text] [Related]
24. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma. Turner JG; Kashyap T; Dawson JL; Gomez J; Bauer AA; Grant S; Dai Y; Shain KH; Meads M; Landesman Y; Sullivan DM Oncotarget; 2016 Nov; 7(48):78896-78909. PubMed ID: 27806331 [TBL] [Abstract][Full Text] [Related]
25. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703 [TBL] [Abstract][Full Text] [Related]
26. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399 [TBL] [Abstract][Full Text] [Related]
27. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas. Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143 [TBL] [Abstract][Full Text] [Related]
28. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells. Ma H; Urquidi V; Wong J; Kleeman J; Goodison S Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399 [TBL] [Abstract][Full Text] [Related]
29. Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB. La Frazia S; Amici C; Santoro MG Antivir Ther; 2006; 11(8):995-1004. PubMed ID: 17302369 [TBL] [Abstract][Full Text] [Related]
30. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946 [TBL] [Abstract][Full Text] [Related]
31. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854 [TBL] [Abstract][Full Text] [Related]
32. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. Won J; Yim J; Kim TK FASEB J; 2002 Dec; 16(14):1943-5. PubMed ID: 12368233 [TBL] [Abstract][Full Text] [Related]
33. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells. Chen R; Zhu J; Dong Y; He C; Hu X Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880 [TBL] [Abstract][Full Text] [Related]
34. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis. Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520 [TBL] [Abstract][Full Text] [Related]
35. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
36. Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated up-regulation of human telomerase reverse transcriptase expression. Furuya M; Tsuji N; Kobayashi D; Watanabe N Int J Oncol; 2009 Apr; 34(4):1061-8. PubMed ID: 19287963 [TBL] [Abstract][Full Text] [Related]
37. Role of diallyl disulfide-mediated cleavage of c-Myc and Sp-1 in the regulation of telomerase activity in human lymphoma cell line U937. Dasgupta P; Sengupta SB Nutrition; 2015; 31(7-8):1031-7. PubMed ID: 26059379 [TBL] [Abstract][Full Text] [Related]
38. 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Pizzimenti S; Briatore F; Laurora S; Toaldo C; Maggio M; De Grandi M; Meaglia L; Menegatti E; Giglioni B; Dianzani MU; Barrera G Free Radic Biol Med; 2006 May; 40(9):1578-91. PubMed ID: 16632118 [TBL] [Abstract][Full Text] [Related]
39. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Guilleret I; Benhattar J Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633 [TBL] [Abstract][Full Text] [Related]
40. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer. Hsu CP; Hsu NY; Lee LW; Ko JL Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]